when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

LAG-3 · pharmadog

TARGET

LAG-3

Lymphocyte-activation gene 3; immune checkpoint.

also known as: cd223, anti-lag-3

drugs

0

catalysts

0

news

9

companies

0

Top drugs

no drugs tagged with this interest yet

🐶 Top companies

no companies tagged with this interest yet

Recent catalysts

no catalysts tagged with this interest yet

Recent news

Regeneron ends eye disease study due to antibody's safety profile
biospace · 17d ago
Regeneron ends eye disease study due to antibody's safety profile
biospace · 17d ago
Regeneron immunotherapy combo comes up short in melanoma trial
biopharma dive · 3mo ago
Regeneron's Phase 3 skin cancer miss adds to mounting failures in LAG-3
endpoints · 3mo ago
Bristol Myers’ legacy lift, Biogen’s blue skies and Regeneron’s murky outlook
biopharma dive · 4mo ago

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

openFDA · ClinicalTrials.gov · pharmadog Linker

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.